Generated by GPT-5-mini| Eran Palti | |
|---|---|
| Name | Eran Palti |
| Occupation | Immunologist; Researcher; Professor |
| Known for | Innate immunity; Toll-like receptor signaling; Vaccine adjuvants |
Eran Palti is an Israeli immunologist and biomedical researcher known for work on innate immunity, pattern recognition receptors, and vaccine adjuvant development. Palti's research spans molecular immunology, translational medicine, and collaborative projects across academic and clinical institutions. His career integrates laboratory investigation, publication in peer-reviewed journals, and participation in international consortia.
Palti completed formative studies at Israeli institutions that included rigorous training in biomedical sciences and clinical research methodologies. He pursued graduate education and postdoctoral work in centers with strong programs in immunology and infectious diseases, collaborating with investigators associated with Weizmann Institute of Science, Hebrew University of Jerusalem, Tel Aviv University, Technion – Israel Institute of Technology, and international laboratories in the United States and Europe. During training he engaged with mentors connected to projects funded by organizations such as the Israel Science Foundation, European Research Council, National Institutes of Health, Wellcome Trust, and academic departments at universities including Harvard University, University of Oxford, Imperial College London, and Stanford University.
Palti established a research program focusing on innate immune sensors and translational immunotherapy within university medical centers and research institutes. He led laboratory teams working on pattern recognition receptors including families related to Toll-like receptor 4, NOD-like receptor, and RIG-I-like receptor signaling, contributing to projects coordinated with clinical units in hospitals like Sheba Medical Center, Rambam Health Care Campus, and collaborations with departments at Sackler Faculty of Medicine, Bar-Ilan University, Ben-Gurion University of the Negev, and international partners at Karolinska Institutet, Pasteur Institute, and Max Planck Society. His career encompassed grant leadership, project management in consortiums with entities such as European Molecular Biology Laboratory, GAVI, the Vaccine Alliance, and private biotech firms from the United Kingdom and United States.
Palti's publications address mechanisms of innate immune activation, adjuvant design, and host-pathogen interactions, appearing in journals allied with organizations like Nature Publishing Group, Cell Press, The Lancet, Proceedings of the National Academy of Sciences, and specialty outlets published by Oxford University Press and Wiley. His research reports examine signaling cascades involving MyD88, TRIF, IRF3, and NF-κB, and explore crosstalk with pathways studied at centers such as Cold Spring Harbor Laboratory, Broad Institute, Scripps Research Institute, and National Institute of Allergy and Infectious Diseases. Palti contributed to multi-author reviews and original articles that cite experimental systems used in laboratories at Johns Hopkins University, University of California, San Francisco, Yale University, and University College London. Collaborative studies include translational assessments employing model systems associated with European Centre for Disease Prevention and Control, World Health Organization, Bill & Melinda Gates Foundation, and industry partners in vaccine development based in Switzerland, Germany, and France.
Throughout his career Palti received recognitions from national and international bodies that support biomedical research. Honors include competitive research awards administered by institutions such as the Israel Academy of Sciences and Humanities, fellowships linked to the European Molecular Biology Organization, prizes administered by foundations like the Israel Cancer Research Fund, and distinctions from academic societies including the Federation of Clinical Immunology Societies and regional chapters affiliated with the International Union of Immunological Societies. He has been invited to present keynote lectures at meetings organized by Cold Spring Harbor Laboratory, Keystone Symposia, European Congress of Immunology, and symposia hosted by universities including Cambridge University, Munich University, and ETH Zurich.
Palti supervised graduate students and postdoctoral fellows enrolled in programs at institutions such as Tel Aviv University, Hebrew University of Jerusalem, Ben-Gurion University of the Negev, and collaborative doctoral programs linked to European Molecular Biology Laboratory and EMBL-EBI. He contributed coursework and seminars to curricula in immunology and translational research at faculties including Sackler Faculty of Medicine and provided training modules used in workshops sponsored by the European Academy of Allergy and Clinical Immunology and professional development courses run by Institute of Biology affiliates. Former mentees have progressed to positions in academia, clinical research units at Rabin Medical Center, and industry roles at biotechnology companies in Israel and the United States.
Palti has served on committees and advisory boards associated with institutions and societies such as the Israel Society for Immunology, European Federation of Immunological Societies, and advisory panels convened by funding bodies like the European Research Council and national ministries. He held editorial responsibilities for journals published by entities including Nature, Frontiers Media, BMC, Springer Nature, and served as peer reviewer for grant agencies like the National Institutes of Health and panels organized by the Wellcome Trust. His professional network spans collaborations with researchers at Mayo Clinic, Cleveland Clinic, Karolinska Institutet, Institut Pasteur, and multiple biotech consortia in Cambridge (UK), Boston, and San Francisco.
Category:Israeli immunologists